Aquestive Therapeutics Reports Positive Topline Data from Part 1

AQST: Aquestive Therapeutics, Inc.
2022-02-25 07:00:00
Aquestive Therapeutics Reports Positive Topline Data from Part 1 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film
Beyond Technical Analysis

免责声明